Genmab | GEN - Creditori Commerciali

Prezzo Delle Azioni
1,790.00
Cambio Giornaliero
-12.50 -0.69%
Mensile
1.91%
Annuale
46.12%
Q2 Previsione
1,699.78




Creditori Commerciali Cambiamento Data
Agios Pharmaceuticals USD 18.36M 1.2M 2025-12
Almirall EUR 258.05M 58.66M 2025-12
Amarin USD 45.36M 8.64M 2025-12
Amgen USD 20.89B 1.25B 2025-12
argenx SE USD 852.2M 369.5M 2025-06
AstraZeneca USD 25.28B 252M 2025-12
Bayer EUR 7.08B 700M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Demant DKK 923M 41M 2025-12
Exelixis USD 29.62M 4.27M 2025-12
Fresenius Medical Care EUR 835.55M 109.7M 2025-12
Galapagos EUR 104.65M 4.02M 2025-12
Genmab DKK 6M 2M 2025-09
GlaxoSmithKline GBP 15.38B 294M 2025-12
GN Store Nord DKK 1.5B 101M 2025-12
GRIFOLS EUR 841M 37.68M 2025-12
Hikma Pharmaceutical USD 715M 104M 2025-12
Insmed USD 79.91M 316K 2025-12
Lonza CHF 471M 3M 2024-12
Merck EUR 2.11B 182M 2025-12
Novartis USD 4.46B 99M 2025-12
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Roche Holding CHF 5.78B 1.27B 2025-12
Sanofi EUR 22.93B 927M 2025-12
UCB EUR 4.04B 755M 2025-12